Overexpression of KRT19 in KU-CSLC cells, a breast cancer stem-like cell line, significantly reduces CSC properties, whereas knockdown of KRT19 in MDA-MB-231 TNBC cells increases tumor growth, sphere formation, cell migration, and drug resistance to doxorubicin [58]. The gene discussed is KRT19; the disease is breast cancer.